The Pennant Group, Inc. Common Stock (PNTG) is a publicly traded Healthcare sector company. As of October 19, 2026, PNTG trades at $40.64 with a market cap of $1.46B and a P/E ratio of 41.78. PNTG moved -2.79% today. Year to date, PNTG is +46.10%; over the trailing twelve months it is +72.00%. Its 52-week range spans $21.18 to $42.74. Analyst consensus is strong buy with an average price target of $46.00. Rallies surfaces PNTG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for PNTG, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $40.64 |
| Market Cap | $1.46B |
| P/E Ratio | 41.78 |
| EPS | $0.94 |
| Dividend Yield | 0.00% |
| 52-Week High | $42.74 |
| 52-Week Low | $21.18 |
| Volume | 201.71K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.10B |
| Net Income | $38.45M |
| Gross Margin | 0.00% |
4 analysts cover PNTG: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $46.00.